Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Breanne Landry

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Pharmaceutics|August 16, 2011
Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell lineHamidreza Montazeri Aliabadi, Breanne Landry, Parvin Mahdipoor, et al.
Biomaterials|January 3, 2012
Supramolecular assemblies in functional siRNA delivery: where do we stand?Hamidreza M Aliabadi, Breanne Landry, Chongbo Sun, et al.
Acta Biomaterialia|January 25, 2011
Lipid substitution on low molecular weight (0.6-2.0 kDa) polyethylenimine leads to a higher zeta potential of plasmid DNA and enhances transgene expressionK C Remant Bahadur, Breanne Landry, Hamidreza Montazeri Aliabadi, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 8, 2012
Effective down-regulation of breast cancer resistance protein (BCRP) by siRNA delivery using lipid-substituted aliphatic polymersHamidreza Montazeri Aliabadi, Breanne Landry, Parvin Mahdipoor, et al.
Macromolecular Bioscience|February 16, 2011
Impact of lipid substitution on assembly and delivery of siRNA by cationic polymersHamidreza Montazeri Aliabadi, Breanne Landry, Remant K Bahadur, et al.
Drug Discovery Today|April 30, 2016
Current attempts to implement siRNA-based RNAi in leukemia modelsHasan Uludağ, Breanne Landry, Juliana Valencia-Serna, et al.
Plos One|September 7, 2012
Effective non-viral delivery of siRNA to acute myeloid leukemia cells with lipid-substituted polyethyleniminesBreanne Landry, Hamidreza Montazeri Aliabadi, Anuja Samuel, et al.
Molecular Therapy. Nucleic Acids|May 13, 2015
Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid LeukemiaBreanne Landry, Juliana Valencia-Serna, Hilal Gul-Uludag, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 9, 2016
Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemiaBreanne Landry, Hilal Gül-Uludağ, Samarwadee Plianwong, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Pharmaceutics|August 16, 2011
Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell lineHamidreza Montazeri Aliabadi, Breanne Landry, Parvin Mahdipoor, et al.
Biomaterials|January 3, 2012
Supramolecular assemblies in functional siRNA delivery: where do we stand?Hamidreza M Aliabadi, Breanne Landry, Chongbo Sun, et al.
Acta Biomaterialia|January 25, 2011
Lipid substitution on low molecular weight (0.6-2.0 kDa) polyethylenimine leads to a higher zeta potential of plasmid DNA and enhances transgene expressionK C Remant Bahadur, Breanne Landry, Hamidreza Montazeri Aliabadi, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 8, 2012
Effective down-regulation of breast cancer resistance protein (BCRP) by siRNA delivery using lipid-substituted aliphatic polymersHamidreza Montazeri Aliabadi, Breanne Landry, Parvin Mahdipoor, et al.
Macromolecular Bioscience|February 16, 2011
Impact of lipid substitution on assembly and delivery of siRNA by cationic polymersHamidreza Montazeri Aliabadi, Breanne Landry, Remant K Bahadur, et al.
Drug Discovery Today|April 30, 2016
Current attempts to implement siRNA-based RNAi in leukemia modelsHasan Uludağ, Breanne Landry, Juliana Valencia-Serna, et al.
Plos One|September 7, 2012
Effective non-viral delivery of siRNA to acute myeloid leukemia cells with lipid-substituted polyethyleniminesBreanne Landry, Hamidreza Montazeri Aliabadi, Anuja Samuel, et al.
Molecular Therapy. Nucleic Acids|May 13, 2015
Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid LeukemiaBreanne Landry, Juliana Valencia-Serna, Hilal Gul-Uludag, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 9, 2016
Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemiaBreanne Landry, Hilal Gül-Uludağ, Samarwadee Plianwong, et al.
Pageof 1